DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Files An 8-K Submission of Matters to a Vote of Security Holders

0

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders.

The annual meeting of shareholders of DENTSPLY SIRONA Inc. was
held on May 24, 2017. The following matters were voted upon at
the Annual Meeting, with the results indicated:
Proposal 1.>>Election of eleven directors to serve a
one-year term and until their successors are duly Elected and
qualified.
NAME
FOR
AGAINST
ABSTAIN
BROKER NON-VOTES
1a.
Michael C. Alfano
189,270,578
8,799,106
830,378
12,288,903
1b.
David K. Beecken
194,104,407
4,700,408
95,247
12,288,903
1c.
Eric K. Brandt
192,781,065
6,025,738
93,259
12,288,903
1d.
Michael J. Coleman
194,317,244
4,488,638
94,180
12,288,903
1e.
Willie A. Deese
194,479,050
4,345,614
75,398
12,288,903
1f.
Thomas Jetter
194,410,683
4,394,265
95,114
12,288,903
1g.
Arthur D. Kowaloff
195,951,503
2,854,390
94,169
12,288,903
1h.
Harry M. Jansen Kraemer
194,173,174
4,632,259
94,629
12,288,903
1i.
Francis J. Lunger
192,627,670
6,196,118
76,274
12,288,903
1j.
Jeffrey T. Slovin
195,735,165
3,074,078
90,819
12,288,903
1k.
Bret W. Wise
194,875,577
3,939,328
85,157
12,288,903
Proposal 2.>>Ratification of Appointment of
PricewaterhouseCoopers LLP as DENTSPLY SIRONA Inc.’s independent
registered public accounting firm for its 2017 fiscal year.
FOR
AGAINST
ABSTAIN
200,967,655
10,160,350
60,960
Proposal 3.>>Non-binding advisory vote on the Company’s
executive compensation.
FOR
AGAINST
ABSTAIN
192,658,681
5,935,874
305,507
Proposal 4.>>Non-binding advisory vote on the frequency of
voting on the Companys executive compensation.
1 YEAR
2 YEARS
3 YEARS
4 YEARS
186,030,032
183,202
12,587,475
99,353


About DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. The Company’s segments include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses. The Company’s principal product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company distributes its products in over 120 countries. It offers brands, such as ANKYLOS, AQUASIL ULTRA, ARTICADENT, XIVE, ORAQIX, XYLOCAINE, ZHERMACK, IN-OVATION, LOFRIC, MAILLEFER, MIDWEST, NUPRO, ORIGO, OSSEOSPEED and PALODENT PLUS.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Recent Trading Information

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) closed its last trading session down -0.42 at 62.73 with 2,106,768 shares trading hands.